Company Strides Pharma Science Limited Bombay S.E.

STAR

INE939A01011

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 05:00:47 2024-12-13 am EST			5-day change	1st Jan Change
716.80 ^INR	+1.54%		+0.55%	+10.55%

Dec. 10	Strides Pharma Science Limited completed the Spin-Off of OneSource Specialty Pharma Limited.	CI
Nov. 21	Strides Pharma Science Limited Announces Appointment of Dr. C Muthulingam as Executive Vice President - Research & Development	CI

Business description: Strides Pharma Science Limited

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Number of employees: 3,065

Sales by Activity: Strides Pharma Science Limited

Fiscal Period: March	2020	2021	2022	2023	2024
Pharmaceutical Business (Excl. Bio-Pharmaceutical Business)	-	33.16B	30.7B	36.88B	40.51B
Pharmaceutical Business	27.52B	-	-	-	-

See all business segments

Geographical breakdown of sales: Strides Pharma Science Limited

Fiscal Period: March	2020	2021	2022	2023	2024
North America	16B	16.65B	12.06B	19.26B	21.48B
Europe	5.03B	7.32B	6.77B	8.37B	9.2B
Africa	2.99B	5.21B	5.71B	4.51B	3.91B
Australia	3.96B	2.45B	3.17B	3.12B	3.71B
Unallocated	-	-	482M	807M	1.6B
India	1.16B	806M	473M	219M	331M
Asia (Excluding India)	223M	623M	1.97B	461M	172M
Others	211M	93.14M	66.78M	144M	116M

See all geographic segments

Managers: Strides Pharma Science Limited

Director	Title	Age	Since
Badree Komandur CEO	Chief Executive Officer	-	2024-05-31
Vikesh Kumar DFI	Director of Finance/CFO	40	2024-05-31
Ramaraju P. V. S COO	Chief Operating Officer	-	2007-04-30
Manjula Ramamurthy CMP	Compliance Officer	-	2017-02-02
Aditya Arun Kumar PRN	Corporate Officer/Principal	-	-

See STRIDES PHARMA SCIENCE LIMITED governance

Members of the board: Strides Pharma Science Limited

Manager	Title	Age	Since
Arun N. Kumar CHM	Chairman	63	-
Homi Rustum Khusrokhan BRD	Director/Board Member	81	2017-05-17
Kausalya Santhanam BRD	Director/Board Member	56	2019-12-10
Ameet Pratapsinh Hariani BRD	Director/Board Member	62	2024-01-31
Subir Chakraborty BRD	Director/Board Member	66	2024-05-31
Aditya Arun Kumar BRD	Director/Board Member	-	-

Composition of the Board of Directors

Shareholders: Strides Pharma Science Limited

Name	Equities	%	Valuation
Pronomz Ventures LLP 17.17 %	15,789,564	17.17 %	305 M ₹
Route One Investment Co. LP 7.232 %	6,650,654	7.232 %	129 M ₹
Amansa Holdings Pvt Ltd. 3.873 %	3,561,313	3.873 %	69 M ₹
Karuna Business Solutions LLP 3.507 %	3,225,050	3.507 %	62 M ₹
Arun Pillai 2.111 %	1,940,996	2.111 %	38 M ₹

List of STRIDES PHARMA SCIENCE LIMITED shareholders

Company details: Strides Pharma Science Limited

Strides Pharma Science Ltd.

Strides House Bannerghatta Road

560076, Bangalore

+91 80 6784 0000

http://www.strides.com

address Strides Pharma Science Limited(STAR)

Group companies: Strides Pharma Science Limited

Name	Category and Sector
Arco Lab Pvt Ltd. Arco Lab Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Strides Pharma Science Ltd., Arco Lab Pvt Ltd. is a company based in Bengaluru, India.	Miscellaneous Commercial Services
Strides Pharma, Inc. Strides Pharma, Inc. Pharmaceuticals: MajorHealth Technology Strides Pharma, Inc. manufactures and distributes pharmaceutical products. The firm operates through the following brand name: JointFlex, Pedia Care, and NiteThru. The company is headquartered in Lambertville, NJ.	Pharmaceuticals: Major
Strides Pharma Global Pte Ltd. Strides Pharma Global Pte Ltd. Pharmaceuticals: MajorHealth Technology Strides Pharma Global Pte Ltd. manufactures and distributes pharmaceutical products. The company was founded in 2013 and is headquartered in Singapore.	Pharmaceuticals: Major
Strides Pharma UK Ltd. Strides Pharma UK Ltd. Medical DistributorsDistribution Services Strides Pharma UK Ltd. engages in the acquisition, development, marketing and distribution of a wide range of generic medicines and other over the counter products. It provides anti emetic, histamine, infective spasticity medicines, cardiovascular, dental, dermatology, diuretics, nasal, lubricants, and steroids medicines. The company was founded in 1993 and is headquartered in Watford, the United Kingdom.	Medical Distributors
Vivimed Life Sciences Pvt Ltd. Vivimed Life Sciences Pvt Ltd. Pharmaceuticals: MajorHealth Technology Vivimed Life Sciences Pvt Ltd. provides pharmaceutical services. The joint venture company is based in Hyderabad, India and was founded in 2017.	Pharmaceuticals: Major

See all subsidiaries

Generic Pharmaceuticals

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.44%	+0.48%	+47.06%	+137.80%	51.3B
OTSUKA HOLDINGS CO., LTD.	-1.79%	-1.35%	+56.25%	+111.51%	30.46B
SANDOZ GROUP AG	-0.51%	-3.36%	+32.77%	-	18.21B
CIPLA LIMITED	+0.13%	-2.04%	+18.97%	+62.38%	13.78B
ZYDUS LIFESCIENCES LIMITED	+0.20%	-1.67%	+52.32%	+110.54%	11.61B
THE MEDICINES COMPANY	-.--%	+0.14%	-	-	6.79B
STADA ARZNEIMITTEL	-.--%	-1.95%	-	-	5.73B
ONO PHARMACEUTICAL CO., LTD.	-1.87%	-3.20%	-33.99%	-39.64%	5.14B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-0.61%	+2.01%	+3.25%	+19.99%	5.21B
Average	-0.45%	-1.47%	+25.23%	+67.10%	16.47B
Weighted average by Cap.	-0.34%	-1.04%	+40.06%	+106.47%